Tags : Serum Institute of India

Insights+: COVID-19 Healthcare News Monthly Updates

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected […]Read More

Novavax and Serum Institute of India Collaborate to Develop and

Shots: Novavax to receive royalties on the sales of vaccines and will provide its Matrix-M vaccine adjuvant to SII. Additionally, the company gets right to commercialize SII-manufactured vaccine in high-income countries, primarily in the travelers and military vaccine markets SII gets access to utilize Novavax’s Matrix-M vaccine adjuvant with its malaria vaccine candidate (R21 malaria […]Read More

Codagenix Collaborates with Serum Institute of India to Co-Develop a

Shots: Codagenix will utilize its deoptimization technology for viral deoptimization, designed several nCoV vaccine candidate genomes, will grow and conduct in-vivo tests of vaccine viruses prior to testing in clinical studies The Serum Institute of India will scale up the manufacturing of vaccines to ensure its availability to meet the public needs. The companies are […]Read More